Search
Search Results
##search.searchResults.foundPlural##
-
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2394PDF: 845HTML: 15050 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1069PDF: 715HTML: 285 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1258PDF: 622HTML: 204 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
1720PDF: 857HTML: 253 -
Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP. immune thrombocytopenia following mRNA vaccine
1963PDF: 484HTML: 1115 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
1810PDF: 427HTML: 108 -
-
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
9724PDF: 5844HTML: 21657 -
Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation Pidotimod in SARS-CoV-2 vaccination
866PDF: 475HTML: 192 -
A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid
1124PDF: 390HTML: 362 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1079PDF: 596HTML: 7592 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2108PDF: 838HTML: 399 -
SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
2813PDF: 670HTML: 1084Cover Letter: 166 -
PREVALENCE OF SERIOUS BACTERIAL INFECTIONS IN CHILDREN WITH SICKLE CELL DISEASE AT KING ABDULAZIZ HOSPITAL, AL AHSA Bacterial infections in children with sickle cell diseas
1309PDF: 495HTML: 179 -
ADVANCES IN THE TREATMENT OF MALARIA
2711PDF: 1049HTML: 5965 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
5675PDF: 3001HTML: 8935Figure Malaria Ricci: 188 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
1593PDF: 753HTML: 262 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4577PDF: 1638HTML: 2656Untitled: 161 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
687PDF: 389HTML: 96 -
EPIDEMIOLOGY OF MALARIA IN ENDEMIC AREAS
4907PDF: 2490HTML: 49520 -
-
-
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1227PDF: 874HTML: 264 -
A SEROPREVALENCE OF HBV, HCV AND HIV-1 AND CORRELATION WITH MOLECULAR MARKERS AMONG MULTI-TRANSFUSED THALASSEMIA PATIENTS IN WESTERN INDIA Incidence of serology & molecular of HIV, HBV and HCV in thalassemia patients
1161PDF: 720HTML: 375 -
-
PROPHYLAXIS OF MALARIA
2883PDF: 946HTML: 17745Figures SChwartz: 129 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1013PDF: 778HTML: 167 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
2843PDF: 965HTML: 3031 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3382PDF: 1012HTML: 23293







